- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02827253
Morphological Changes of the Brain by MRI in Chronic Kidney Disease (KIDBRAIN)
Cohort Study of Morphological Changes of the Brain by MRI in Chronic Kidney Disease Patients
The purpose of this study is to describe brain´s morphological changes induced by chronic kidney disease (CKD) in advanced stages (stages 4 and 5 defined by KDOQI guidelines) and also by haemodialysis using MRI.
Based on the hypothesis that hypotension may cause damage in some organs including brain the investigators study if intradialytic hypotension (IDH) causes any type of changes in gray and white matter of the brain.
Study Overview
Status
Intervention / Treatment
Detailed Description
There will be two groups: one in haemodialysis treatment and the other with chronic kidney disease patients in advanced stages (stages 4 and 5 defined by KDOQI guidelines).
Both groups will be evaluated with a MRI without contrast. A second MRI to identify brain´s morphological changes will be performed in patients of the first group a year later and in patients of the second group that will have been begun haemodialysis six months after.
In a first transverse evaluation, eighteen haemodialysis sessions from the first group will be studied with a retrospective analysis. The first three sessions of each month for six months before the MRI will be considered.
In each session the investigators will collect haemodynamic variables (systolic arterial blood pressure pre and post dialysis), intradialytic hypotension based on different definitions (Nadir90, Nadir100, Fall20, Fall30) and proper haemodialysis variables (KtV, convective transport).
In the first group and patients with CKD that will start haemodialysis, the investigators analyse the variables considered in the transverse evaluation until complete one year follow up.
Statistical analysis will be done with SPSS version 20.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Juan M. López Gómez, PhD
- Phone Number: 678 292 696
- Email: juanmlopez@senefro.org
Study Contact Backup
- Name: Santiago Cedeño Mora, MD
- Phone Number: 692258295
- Email: santicedeno@outlook.com
Study Locations
-
-
-
Madrid, Spain, 28007
- Recruiting
- Hospital General Universitario Gregorio Marañon
-
Contact:
- Santiago Cedeño Mora, MD
- Phone Number: 692258295
- Email: santicedeno@outlook.com
-
Contact:
- Juan López Gomez, PhD
- Phone Number: 678 292 696
- Email: juanmlopez@senefro.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Prevalent patients of haemodialysis (6 months minimum)
- Patients with CKD (stages 4 and 5)
- Informed consent signed
Exclusion Criteria:
- Refusion to participate in the study
- Presence of contraindications for MRI
- Presence of clinic neurologic disorders
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Predialysis
Patients with CKD (4 and 5 stages by KDOQI guidelines) underwent MRI to obtain in vivo images of brain anatomy that were subsequently analyzed by the data processing package FreeSurfer (version 5.3).
A MRI 6 months after starting haemodialysis will be performed to analyze changes in gray and white matter of the brain.
|
MRI will be performed during interdialysis period in the haemodialysis group.
MRI will be performed at the beginning of the study in predialysis group.
|
Haemodialysis
Patients with end stage of renal disease (ESRD) in haemodialysis underwent MRI to obtain in vivo images of brain anatomy that were subsequently analyzed by the data processing package FreeSurfer (version 5.3).
A one year follow up MRI will be performed to analyze the changes in gray and white matter of the brain.
|
MRI will be performed during interdialysis period in the haemodialysis group.
MRI will be performed at the beginning of the study in predialysis group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Morphological changes in gray matter of haemodialysis group
Time Frame: one year
|
area (mm2), volume (mm3), mean cortical thick (mm) of each structure of brain
|
one year
|
Morphological changes in white matter of haemodialysis group
Time Frame: one year
|
Diffusion weighted imaging: fractional anisotropy, median diffusivity, radial diffusivity, volume ratio.
|
one year
|
Morphological changes in gray matter of predialysis group that start haemodialysis
Time Frame: six months
|
area (mm2), volume (mm3), mean cortical thick (mm) of each structure of brain
|
six months
|
Morphological changes in white matter of predialysis group that start haemodialysis
Time Frame: six months
|
Diffusion weighted imaging: fractional anisotropy, median diffusivity, radial diffusivity, volume ratio.
|
six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Related factors that have influence in morphological changes in haemodialysis group
Time Frame: one year
|
age (years), time in dialysis (months), time of treatment (hours), KtV, convective transport (L/session), anemia (hemoglobin, index resistance erythropoietin), inflammation (PCR), intradialytic hypotension (Nadir90, Nadir100, Fall20, Fall30).
|
one year
|
Related factors that have influence in morphological changes in predialysis group
Time Frame: six months
|
age, etiology of CKD, proteinuria, blood pressure, comorbidities.
|
six months
|
Collaborators and Investigators
Investigators
- Study Chair: Juan M. López Gómez, PhD, Hospital General Universitario Gregorio Marañon
- Principal Investigator: Santiago Cedeño Mora, MD, Hospital General Universitario Gregorio Marañon
- Principal Investigator: Manuel Desco, PhD, Hospital General Universitario Gregorio Marañon
Publications and helpful links
General Publications
- Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015 Apr;26(4):957-65. doi: 10.1681/ASN.2013101086. Epub 2014 Sep 18.
- McIntyre CW, Goldsmith DJ. Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? Kidney Int. 2015 Jun;87(6):1109-15. doi: 10.1038/ki.2015.62. Epub 2015 Apr 8.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HGUGM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Disease Requiring Chronic Dialysis
-
VA Office of Research and DevelopmentRecruitingChronic Kidney Disease (CKD) Stage 5 | Kidney Dysfunction Requiring Dialysis (KDRD) | Dialysis DependencyUnited States
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedChronic Kidney Disease Requiring Chronic DialysisUnited States
-
Fundación SenefroUnknownChronic Kidney Disease Requiring Chronic DialysisSpain
-
Hospital Universitario Infanta LeonorCompletedChronic Kidney Disease Requiring Chronic DialysisSpain
-
University of CopenhagenStine Kristensen; Gita Krüger Mørch; Rizwan Butt; Ditte HansenNot yet recruitingChronic Kidney Disease Requiring Chronic DialysisDenmark
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Duke... and other collaboratorsCompletedChronic Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisUnited States
-
Pavol Jozef Safarik UniversityDialysis Services Fresenius Medical Care Slovakia; Private Health Institution...CompletedChronic Kidney Disease Requiring Chronic DialysisSlovakia
-
McGill University Health Centre/Research Institute...CompletedChronic Kidney Disease Requiring Chronic Dialysis
-
Instituto Nacional de Cardiologia Ignacio ChavezRenal Research InstituteUnknownChronic Kidney Disease Requiring Chronic Dialysis | HemodiafiltrationMexico
-
Universidade Estadual Paulista Júlio de Mesquita...UnknownChronic Kidney Disease Requiring Chronic Dialysis | Cost-effectiveness AnalysisBrazil
Clinical Trials on MRI
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Seoul National University Bundang HospitalBayerCompletedTraumaKorea, Republic of
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOsteosarcoma | Ewing Sarcoma | Paget's DiseaseUnited States
-
Abbott Medical DevicesCompletedAdverse Effect of MRI on an Implanted Pacemaker Lead | Adverse Effect of MRI on an Implanted PacemakerUnited States, Netherlands, Australia, Belgium, Finland
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
University of EdinburghActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisUnknownBrain Injury, Coma | Cardiac Arrest (CA) | Traumatic Brain Injury (TBI) | Aneurysmal Subarachnoid Hemorrhages (aSAH)France
-
Sheba Medical CenterUnknown
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupUnknownBreast Cancer | BIRADS 3 | BIRADS 4 | BIRADS 5United States